世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
47期
53-54
,共2页
依达拉奉%脑出血患者%醒脑静注射液
依達拉奉%腦齣血患者%醒腦靜註射液
의체랍봉%뇌출혈환자%성뇌정주사액
Edaravone%cerebral hemorrhage%Xingnaojing Injection
目的 分析依达拉奉治疗急性脑出血患者的临床效果.方法 2014年3月至2015年1月收治急性脑出血患者110例,随机分成对照组和观察组,各55例,对照组按照常规治疗原则进行治疗,观察组在对照组的基础上采用依达拉奉治疗,两组连续进行治疗21d.结果 观察组痊愈患者25例,效果显著患者20例,无效患者8例,死亡患者2例,总有效率达96.36%;对照组痊愈患者15例,效果显著患者20例,无效患者18例,死亡患者2例,总有效率63.63%,两组比较差异有统计学意义.观察组和对照组治疗前后的评分具有很大差异,两组治疗后比较差异具有统计学意义.结论 依达拉奉治疗急性脑出血患者临床治疗效果显著.
目的 分析依達拉奉治療急性腦齣血患者的臨床效果.方法 2014年3月至2015年1月收治急性腦齣血患者110例,隨機分成對照組和觀察組,各55例,對照組按照常規治療原則進行治療,觀察組在對照組的基礎上採用依達拉奉治療,兩組連續進行治療21d.結果 觀察組痊愈患者25例,效果顯著患者20例,無效患者8例,死亡患者2例,總有效率達96.36%;對照組痊愈患者15例,效果顯著患者20例,無效患者18例,死亡患者2例,總有效率63.63%,兩組比較差異有統計學意義.觀察組和對照組治療前後的評分具有很大差異,兩組治療後比較差異具有統計學意義.結論 依達拉奉治療急性腦齣血患者臨床治療效果顯著.
목적 분석의체랍봉치료급성뇌출혈환자적림상효과.방법 2014년3월지2015년1월수치급성뇌출혈환자110례,수궤분성대조조화관찰조,각55례,대조조안조상규치료원칙진행치료,관찰조재대조조적기출상채용의체랍봉치료,량조련속진행치료21d.결과 관찰조전유환자25례,효과현저환자20례,무효환자8례,사망환자2례,총유효솔체96.36%;대조조전유환자15례,효과현저환자20례,무효환자18례,사망환자2례,총유효솔63.63%,량조비교차이유통계학의의.관찰조화대조조치료전후적평분구유흔대차이,량조치료후비교차이구유통계학의의.결론 의체랍봉치료급성뇌출혈환자림상치료효과현저.
Objective: To analyze the clinical effect of edaravone in the treatment of patients with acute cerebral hemorrhage. Methods:2014 March to 2015 in our hospital in January in the acute cerebral hemorrhage patients in 110 cases, were randomly divided into control group and observation group, 55 cases, two groups of continuous 21 days of treatment.Results: The obser-vation group 25 cases were cured, 20 cases of patients with significant effect, ineffective in 8 patients, death 2 cases of patients, the total effective rate was 96.36%; control group, 15 cases of patients cured, 20 cases of patients with significant effect, were ineffec-tive in 18 cases, death in 2 cases, the total efficiency of 63.63%, the difference between the two groups have statistical significance. Before and after treatment, the scores of the observation group and the control group were significantly different, and the differ-ence between the two groups was statistically significant.Conclusion:Significant bleeding in patients with clinical therapeutic effect of edaravone in treatment of acute cerebral.
